Form 1-K Issuer Information


FORM 1-K

UNITED STATE
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 1-K

OMB APPROVAL

OMB Number:  ####-####

Estimated average burden hours per response: ##.#

1-K: Filer Information

Issuer CIK
0001778651 
Issuer CCC
XXXXXXXX 
Is filer a shell company?
o Yes x No
Is the electronic copy of an official filing submitted in paper format?
o
File Number
 
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination?
o Yes x No
Successor File Number
 
Is this a LIVE or TEST Filing?
x LIVE o TEST
Would you like a Return Copy?
o
Period
12-31-2021 

Submission Contact Information

Name
 
Phone
 
E-Mail Address
 
Notify via Filing Website only?
o

1-K: Tab 1 Notification

This Form 1-K is to provide an
x Annual Report o Special Financial Report for the fiscal year
Fiscal Year End
12-31-2021 
Exact name of issuer as specified in the issuer's charter
Juva Life Inc. 
CIK
0001778651 
Jurisdiction of Incorporation / Organization
BRITISH COLUMBIA, CANADA  
I.R.S. Employer Identification Number
00-0000000 

Address of Principal Executive Offices

Address 1
Suite 1400 - 885 West Georgia Street 
Address 2
 
City
Vancouver 
State/Country
BRITISH COLUMBIA, CANADA  
Mailing Zip/ Postal Code
V6C 3E8 
Phone
833-333-5882 
Title of each class of securities issued pursuant to Regulation A
Units (each consisting of one Common Share, no par value, and one-half of one Common Share Purchase Warrant) and Common Shares underlying Warrants 

1-K: Summary Information Regarding Prior Offering and Proceeds

Summary Information

oThe following information must be provided for any Regulation A offering that has terminated or completed prior to the filing of this Form 1-K, unless such information has been previously reported in a manner permissible under Rule 257. If such information has been previously reported, check this box and leave the rest of Part I blank.

Commission File Number of the offering statement
024-11014 
Date of qualification of the offering statement
08-20-2019 
Date of commencement of the offering
08-23-2019 
Amount of securities qualified to be sold in the offering
57000000 
Amount of securities sold in the offering
36198782 
Price per security
$ 0.5000 
The portion of aggregate sales attributable to securities sold on behalf of the issuer
$ 18099391.00 
The portion of the aggregate sales attributable to securities sold on behalf of selling securityholders
$ 0.00 

Fees in connection with this offering and names of service providers.

Underwriters - Name of Service Provider
Underwriters - Fees
$ 0.00 
Sales Commissions - Name of Service Provider
Dalmore Group, LLC
Sales Commissions - Fee
$ 236666.00 
Finders' Fees - Name of Service Provider
Finders' Fees - Fees
$ 0.00 
Audit - Name of Service Provider
Davidson & Company LLP
Audit - Fees
$ 74000.00 
Legal - Name of Service Provider
Greenberg Traurig and McMillan
Legal - Fees
$ 85475.00 
Promoters - Name of Service Provider
Promoters - Fees
$ 0.00 
Blue Sky Compliance - Name of Service Provider
Various states
Blue Sky Compliance - Fees
$ 4700.00 
CRD Number of any broker or dealer listed
136352 
Net proceeds to the issuer
$ 17550081.00 
Clarification of responses (if necessary)
The Units were sold at a purchase price of $0.50 per Unit. Each whole Warrant is exercisable over an 18-month period following the date of issuance at an exercise price of $0.75 per warrant share. Other fees deducted included $148,469 paid to Dealmaker 
Juva Life (CE) (USOTC:JUVAF)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 5์›”(5) 2024 ์œผ๋กœ 6์›”(6) 2024 Juva Life (CE) ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.
Juva Life (CE) (USOTC:JUVAF)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 6์›”(6) 2023 ์œผ๋กœ 6์›”(6) 2024 Juva Life (CE) ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.